Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain Investigators assessed the dynamics of oligodendrocyte generation and myelination in the human brain. They conclude that oligodendrocyte turnover contributes minimally to myelin modulation in human white matter and that this instead may be carried out by mature oligodendrocytes, which may facilitate rapid neural plasticity. [Cell] Abstract | Graphical Abstract | Press Release Cells of Origin in the Embryonic Nerve Roots for NF1-Associated Plexiform Neurofibroma Using cell-lineage tracing, scientists identified a population of GAP43+ PLP+ precursors in embryonic nerve roots as the cells of origin for neurofibromatosis type 1 tumors and report a non-germline neurofibroma model for preclinical drug screening to identify effective therapies. [Cancer Cell] Abstract | Graphical Abstract | Press Release hPSC-Derived Maturing GABAergic Interneurons Ameliorate Seizures and Abnormal Behavior in Epileptic Mice Researchers demonstrate that human pluripotent stem cell (hPSC)-derived maturing GABAergic interneurons (mGINs) migrate extensively and integrate into dysfunctional circuitry of the epileptic mouse brain. Using optogenetic approaches, they found that grafted mGINs generate inhibitory postsynaptic responses in host hippocampal neurons. [Cell Stem Cell] Abstract | Graphical Abstract | Press Release Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson’s Disease The authors provide a comprehensive preclinical assessment of human embryonic stem cells (hESC)-derived midbrain dopamine neurons in a rat model of Parkinson’s disease. They show that hESC-derived dopamine neurons can project sufficiently long distances for use in humans, fully regenerate midbrain-to-forebrain projections, and innervate correct target structures. [Cell Stem Cell] Full Article | Graphical Abstract | Press Release Modeling Non-Syndromic Autism and the Impact of TRPC6 Disruption in Human Neurons Using multiple models, such as dental pulp cells, induced pluripotent stem cell-derived neuronal cells and mouse models, investigators demonstrate that TRPC6 reduction or haploinsufficiency leads to altered neuronal development, morphology and function. [Mol Psychiatry] Abstract | Press Release Drp1 Inhibition Attenuates Neurotoxicity and Dopamine Release Deficits In Vivo Scientists show that inhibition of the mitochondrial fission GTPase dynamin-related protein-1 (Drp1) using gene-based and small-molecule approaches attenuates neurotoxicity and restores pre-existing striatal dopamine release deficits in animal models of Parkinson’s disease. [Nat Commun] Full Article | Press Release iPSC-Derived Dopamine Neurons Reveal Differences between Monozygotic Twins Discordant for Parkinson’s Disease Investigators applied induced pluripotent stem cell (iPSC) technology for Parkinson’s disease modeling using monozygotic twins’ fibroblasts to evaluate and dissect the genetic and nongenetic contributions. Utilizing fluorescence-activated cell sorting, they obtained a homogenous population of “footprint-free” iPSC-derived midbrain dopaminergic neurons. [Cell Rep] Full Article | Graphical Abstract | Press Release Direct Lineage Conversion of Adult Mouse Liver Cells and B Lymphocytes to Neural Stem Cells Researchers used transduction of doxycycline-inducible transcription factors to generate stable tripotent neural stem cells (NSCs). The induced NSCs maintained their characteristics in the absence of exogenous factor expression and were transcriptionally, epigenetically, and functionally similar to primary brain-derived NSCs. [Stem Cell Rep] Full Article | Graphical Abstract | Press Release |